tiprankstipranks
Atossa repots topline data from the KARISMA-Endoxifen Phase 2 study
PremiumThe FlyAtossa repots topline data from the KARISMA-Endoxifen Phase 2 study
22d ago
Atossa preliminary analysis phase 2 trial of z-endoxifen met primary endpoint
Premium
The Fly
Atossa preliminary analysis phase 2 trial of z-endoxifen met primary endpoint
26d ago
Atossa Therapeutics announces recognition of Breast Cancer Awarenss Month
Premium
The Fly
Atossa Therapeutics announces recognition of Breast Cancer Awarenss Month
2M ago
Atossa announces appointment of Parks as VP, Investor, Public Relations
PremiumThe FlyAtossa announces appointment of Parks as VP, Investor, Public Relations
3M ago
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
Premium
The Fly
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
4M ago
Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
Premium
The Fly
Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
4M ago
Atossa Therapeutics set to join Russell 3000 Index
PremiumThe FlyAtossa Therapeutics set to join Russell 3000 Index
5M ago
Atossa Therapeutics announces support for Phase 2 SMART study
Premium
The Fly
Atossa Therapeutics announces support for Phase 2 SMART study
6M ago
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
Premium
The Fly
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100